-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, August 18, on August 16, the Sichuan Provincial Food and Drug Administration issued a notice on its official website, informing that Huixing Pharmaceutical’s Omeprazole Enteric-coated Capsules, Xinrentai Pharmaceutical Longan Meat, and Xinli Traditional Chinese Medicine Decoction Company Poria skin 3 The batch of drugs does not meet the regulations
.
.
The original text is as follows:
Announcement of theSichuan Provincial Drug Administration on 3 batches of drugs not in compliance with the regulations ( No.
9 of 2021 )
9 of 2021 )
2021 No.
9 Hao
9 Hao
By the Food and Drug Mianyang City and other three pharmaceutical inspection institutions, marked as Shanxi, Tianjin Hui Xing Pharmaceutical Co.
, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
1.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
According to the inspection by Luzhou City Market Inspection and Testing Center, a batch of longan meat produced by Sichuan Xinrentai Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
According to the inspection of Panxi Vanadium and Titanium Inspection and Testing Institute, a batch of Poria cocos produced by Panzhihua Xinli Chinese Medicine Decoction Pieces Co.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
2.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
Third, Sichuan Province and Drug Administration requirements of the relevant drug regulatory authorities based on "Drug Administration Law of the People's Republic of China", the organization of these enterprises and units of production and sales of fake medicines of inferior quality products illegal investigation, the results of the investigation public in accordance with regulations
.
.
Hereby inform
.
.
Attachment: List of 3 batches of non-compliant drugs
Medical Network, August 18, on August 16, the Sichuan Provincial Food and Drug Administration issued a notice on its official website, informing that Huixing Pharmaceutical’s Omeprazole Enteric-coated Capsules, Xinrentai Pharmaceutical Longan Meat, and Xinli Traditional Chinese Medicine Decoction Company Poria skin 3 The batch of drugs does not meet the regulations
.
.
The original text is as follows:
Announcement of the Sichuan Provincial Drug Administration on 3 batches of drugs not in compliance with the regulations ( No.
9 of 2021 )
9 of 2021 )
2021 No.
9 Hao
9 Hao
By the Food and Drug Mianyang City and other three pharmaceutical inspection institutions, marked as Shanxi, Tianjin Hui Xing Pharmaceutical Co.
, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
1.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
According to the inspection by Luzhou City Market Inspection and Testing Center, a batch of longan meat produced by Sichuan Xinrentai Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
According to the inspection of Panxi Vanadium and Titanium Inspection and Testing Institute, a batch of Poria cocos produced by Panzhihua Xinli Chinese Medicine Decoction Pieces Co.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
2.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
Third, Sichuan Province and Drug Administration requirements of the relevant drug regulatory authorities based on "Drug Administration Law of the People's Republic of China", the organization of these enterprises and units of production and sales of fake medicines of inferior quality products illegal investigation, the results of the investigation public in accordance with regulations
.
.
Hereby inform
.
.
Attachment: List of 3 batches of non-compliant drugs
Medical Network, August 18, on August 16, the Sichuan Provincial Food and Drug Administration issued a notice on its official website, informing that Huixing Pharmaceutical’s Omeprazole Enteric-coated Capsules, Xinrentai Pharmaceutical Longan Meat, and Xinli Traditional Chinese Medicine Decoction Company Poria skin 3 The batch of drugs does not meet the regulations
.
.
The original text is as follows:
Announcement of the Sichuan Provincial Drug Administration on 3 batches of drugs not in compliance with the regulations ( No.
9 of 2021 )
Sichuan Pharmaceutical Drug Drug Administration on 3 Notice batches of the drug does not comply with the provisions of (2021 No. 9 of 2021 )
9 numbers)
2021 No.
9 Hao
2021 No. 9 Hao
9 Hao
By the Food and Drug Mianyang City and other three pharmaceutical inspection institutions, marked as Shanxi, Tianjin Hui Xing Pharmaceutical Co.
, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
Enterprise business enterprise, Ltd.
and other three pharmaceutical production enterprises 3 batches of pharmaceutical production of non-compliance
.
The relevant situation is now announced as follows:
1.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
A batch of omeprazole enteric-coated capsules produced by Shanxi Jinhuahuixing Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations after being inspected by the Mianyang Food and Drug Inspection Institute, and the non-compliant item is the dissolution rate
.
According to the inspection by Luzhou City Market Inspection and Testing Center, a batch of longan meat produced by Sichuan Xinrentai Pharmaceutical Co.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
, Ltd.
is not in compliance with the regulations, and the non-compliant item is moisture
.
According to the inspection of Panxi Vanadium and Titanium Inspection and Testing Institute, a batch of Poria cocos produced by Panzhihua Xinli Chinese Medicine Decoction Pieces Co.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
, Ltd.
did not meet the requirements.
The items that did not meet the requirements were total ash and acid-insoluble ash
.
2.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
For the above-mentioned non-compliant drugs, the drug supervision and administration department has required relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
, to investigate the reasons for non-compliance and effectively rectify them
.
Third, Sichuan Province and Drug Administration requirements of the relevant drug regulatory authorities based on "Drug Administration Law of the People's Republic of China", the organization of these enterprises and units of production and sales of fake medicines of inferior quality products illegal investigation, the results of the investigation public in accordance with regulations
.
Bad medicine bad medicine bad medicine.
Hereby inform
.
.
Attachment: List of 3 batches of non-compliant drugs
Attachment: List of 3 batches of non-compliant drugs 
